# Rosuvastatin (Crestor) in Friedreich Ataxia

> **NCT02705547** · EARLY_PHASE1 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 12 (actual)

## Conditions studied

- Friedreich Ataxia

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT02705547
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-08-04
- **Final completion:** 2017-08-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02705547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02705547, "Rosuvastatin (Crestor) in Friedreich Ataxia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02705547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*